Clinical and pathophysiological consequences of on-demand treatment with PPI in endoscopy-negative reflux disease. Is rebound hypersecretion of acid a problem?-Reference-Cited by-同舟云学术

Clinical and pathophysiological consequences of on-demand treatment with PPI in endoscopy-negative reflux disease. Is rebound hypersecretion of acid a problem?

Published:2010-12-09 Issue:4 Volume:46 Page:398-405
ISSN:0036-5521
Container-title:Scandinavian Journal of Gastroenterology
language:en
Short-container-title:Scandinavian Journal of Gastroenterology

Author:

Juul-Hansen Paul,Rydning Andreas

Publisher

Informa UK Limited

Subject

Gastroenterology

Link

http://www.tandfonline.com/doi/pdf/10.3109/00365521.2010.537684

Reference19 articles.

1. Healing and relapse of severe peptic esophagitis after treatment with omeprazole

2. Temporary Cessation of Long-Term Maintenance Treatment with Omeprazole in Patients with H2-Receptor-Antagonist-Resistant Reflux Oesophagitis

3. Rebound intragastric hyperacidity after abrupt withdrawal of histamine H2 receptor blockade.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rebound Acid Hypersecretion after Withdrawal of Long-Term Proton Pump Inhibitor (PPI) Treatment—Are PPIs Addictive?;International Journal of Molecular Sciences;2024-05-17

2. Examination on Factors Affecting Symptom Change after Drug Withdrawal in Patients with Mild Erosive Gastroesophageal Reflux Disease Undergoing Symptom-Controlled Maintenance Therapy with Acid-Secretion Inhibition Drugs;Digestion;2023

3. ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease;American Journal of Gastroenterology;2021-11-22

4. Problems Associated with Deprescribing of Proton Pump Inhibitors;International Journal of Molecular Sciences;2019-11-02

5. Sustained efficacy following resolution of frequent heartburn with an over-the-counter regimen of esomeprazole 20 mg or placebo for 14 days: two randomized trials;BMC Gastroenterology;2018-05-22